Advertisement
Advertisement

BBOT

BBOT logo

BridgeBio Oncology Therapeutics, Inc. Common Stock

9.33
USD
Sponsored
+0.55
+6.26%
Aug 07, 15:58 UTC -4
Closed
exchange

After-Market

9.32

-0.01
-0.11%

BridgeBio Oncology Therapeutics, Inc. Common Stock Profile

About

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K? malignancies. BridgeBio Oncology Therapeutics, formerly known as Helix Acquisition Corp. II, is based in SOUTH SAN FRANCISCO.

Info & Links

CEO

Eli Wallace

Headquarters

256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://bbotx.com/

Auditor

Deloitte & Touche LLP

Share holders

57

Employees

92

BridgeBio Oncology Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

746.60M

Enterprise Value

693.94M

Enterprise Value/EBITDA(ttm)

-7.29

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-21.33%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-95.17M

Net Income Available to Common(ttm)

-86.86M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.36

52-Week Change

--

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

80.11M

Dividend Yield

0.00%

Float4

60.56M

% Held by Insiders

24.40%

% Held by Institutions

54.89%

Balance Sheet

Total Cash(mrq)

252.28M

Total Cash Per Share(mrq)

3.15

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.16%

Quick Ratio(mrq)

6.16%

Book Value Per Share(mrq)

4.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-35.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement